Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
The Debate on Overpayment In Medicare Advantage: Pulling It together
Health Affairs Forefront has published articles that advance two diametrically opposing assessments of issues regarding the Medicare Advantage program. Ginsburg and Lieberman discuss them and why it is important to come to agreement.
-
From Vision to Design in Advancing Medicare Payment Reform: A Blueprint for Population-Based Payments
With Medicare spending growth over the next decade expected to exceed GDP growth, the trust fund projected to be depleted in 2026, and evidence of persistent and pervasive waste and disparities in health care, attention has returned to the role of payment reform in controlling Medicare spending growth and driving more efficient and equitable care delivery.
Posted in -
Money for the Infrastructure Bill is Coming at the Expense of Medicare Part D
The $1 trillion infrastructure bill will leave a lot of chronically ill people by the side of the road.
Posted in -
Options for Containing the Cost of a New Medicare Dental, Hearing, and Vision Benefit
USC-Brookings Schaeffer Initiative for Health Policy expert Matthew Fiedler analyzes options for reducing the cost of adding dental, hearing and vision coverage to Medicare.
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Do Medicare’s Facility Fees Incentivize Hospitals to Vertically Integrate with Oncologists?
A new paper examining whether or not hospitals strategically choose to vertically integrate with clinical oncologists in order to capture facility fees, a commonly cited reason for increased consolidation in the healthcare market.
Categorized in -
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members
A new Schaeffer Center study comparing Medicare Part D prescription drug prices with those paid by Costco members finds that the federal government overpaid on roughly half of the most common generic medicines in 2018.
Categorized in -
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Categorized in -
Access to the 340B Drug Pricing Program: Is There Evidence of Strategic Hospital Behavior?
Some hospitals adjust their measure that identifies hospitals that treat a disproportionate share of low-income patients to gain 340B eligibility.
Categorized in -
Assessing the Quality of SK&A’s Office-Based Physician Database for Identifying Oncologists
Schaeffer experts assess the quality of one of the most commonly used commercial databases, SK&A’s office-based physician database.
Categorized in -
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years.
Categorized in